Corneal transduction by intra-stromal injection of AAV vectors in vivo in the mouse and Ex vivo in human explants

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Hippert, Claire ^a,b   Ibanes, Sandy ^a,b   Serratrice, Nicolas ^a,b   Court, Franck ^a,b   Malecaze, François ^c,d   Kremer, Eric J ^a,b   Kalatzis, Vasiliki ^a,b  

^a CNRS   (France)

^b UNIV MONTPELLIER   (France)

^c INSERM   (France)

^d CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; MESSENGER RNA;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 2; ADENO ASSOCIATED VIRUS 8; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA CELL; CORNEA OPACITY; EX VIVO STUDY; EXPLANT; GENE EXPRESSION; GENE TRANSFER; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NONHUMAN; SEROTYPE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BIOSYNTHESIS; CORNEA; CORNEA STROMA; CYTOLOGY; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; MALE; METABOLISM; METHODOLOGY; VIROLOGY;

MURINAE; MUS;

ANIMALS; CORNEA; CORNEAL KERATOCYTES; CORNEAL STROMA; DEPENDOVIRUS; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; MALE; MICE; RNA, MESSENGER; TRANSDUCTION, GENETIC;

EID: 84859851580     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035318     Document Type: Article

References (47)

1. Klausner EA, Peer D, Chapman RL, Multack RF, Andurkar SV, (2007) Corneal gene therapy. J Control Release 124: 107-133.
2. West-Mays JA, Dwivedi DJ, (2006) The keratocyte: corneal stromal cell with variable repair phenotypes. Int J Biochem Cell Biol 38: 1625-1631.
3. Jhanji V, Sharma N, Agarwal T, Vajpayee RB, (2010) Alternatives to allograft corneal transplantation. Curr Opin Ophthalmol 21: 301-309.
4. Williams KA, Coster DJ, (2010) Gene therapy for diseases of the cornea- a review. Clin Experiment Ophthalmol 38: 93-103.
5. Mohan RR, Sharma A, Netto MV, Sinha S, Wilson SE, (2005) Gene therapy in the cornea. Prog Retin Eye Res 24: 537-559.
6. Hao J, Li SK, Kao WW, Liu CY, (2010) Gene delivery to cornea. Brain Res Bull 81: 256-261.
7. Borras T, Tamm ER, Zigler JS Jr, (1996) Ocular adenovirus gene transfer varies in efficiency and inflammatory response. Invest Ophthalmol Vis Sci 37: 1282-1293.
8. George AJ, Arancibia-Carcamo CV, Awad HM, Comer RM, Fehevari Z, et al. (2000) Gene delivery to the corneal endothelium. Am J Respir Crit Care Med 162: S194-200.
9. Kamata Y, Okuyama T, Kosuga M, O'Hira A, Kanaji A, et al. (2001) Adenovirus-mediated gene therapy for corneal clouding in mice with mucopolysaccharidosis type VII. Mol Ther 4: 307-312.
10. Yu H, Wu J, Li H, Wang Z, Chen X, et al. (2007) Inhibition of corneal neovascularization by recombinant adenovirus-mediated sFlk-1 expression. Biochem Biophys Res Commun 361: 946-952.
11. Mohan RR, Schultz GS, Hong JW, Wilson SE, (2003) Gene transfer into rabbit keratocytes using AAV and lipid-mediated plasmid DNA vectors with a lamellar flap for stromal access. Exp Eye Res 76: 373-383.
12. Liu J, Saghizadeh M, Tuli SS, Kramerov AA, Lewin AS, et al. (2008) Different tropism of adenoviruses and adeno-associated viruses to corneal cells: implications for corneal gene therapy. Mol Vis 14: 2087-2096.
13. Bemelmans AP, Arsenijevic Y, Majo F, (2009) Efficient lentiviral gene transfer into corneal stroma cells using a femtosecond laser. Gene Ther 16: 933-938.
14. Sharma A, Tovey JC, Ghosh A, Mohan RR, (2010) AAV serotype influences gene transfer in corneal stroma in vivo. Exp Eye Res 91: 440-448.
15. Carlson EC, Liu CY, Yang X, Gregory M, Ksander B, et al. (2004) In vivo gene delivery and visualization of corneal stromal cells using an adenoviral vector and keratocyte-specific promoter. Invest Ophthalmol Vis Sci 45: 2194-2200.
16. Bainbridge JW, Smith AJ, Barker SS, Robbie S, Henderson R, et al. (2008) Effect of gene therapy on visual function in Leber's congenital amaurosis. N Engl J Med 358: 2231-2239.
17. Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, et al. (2008) Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med 358: 2240-2248.
18. Toti P, Tosi GM, Traversi C, Schurfeld K, Cardone C, et al. (2002) CD-34 stromal expression pattern in normal and altered human corneas. Ophthalmology 109: 1167-1171.
19. Sosnova M, Bradl M, Forrester JV, (2005) CD34+ corneal stromal cells are bone marrow-derived and express hemopoietic stem cell markers. Stem Cells 23: 507-515.
20. Brissette-Storkus CS, Reynolds SM, Lepisto AJ, Hendricks RL, (2002) Identification of a novel macrophage population in the normal mouse corneal stroma. Invest Ophthalmol Vis Sci 43: 2264-2271.
21. Chintakuntlawar AV, Zhou X, Rajaiya J, Chodosh J, (2010) Viral capsid is a pathogen-associated molecular pattern in adenovirus keratitis. PLoS Pathog 6: e1000841.
22. Nilsson EC, Storm RJ, Bauer J, Johansson SM, Lookene A, et al. (2011) The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis. Nat Med 17: 105-109.
23. Kremer EJ, Boutin S, Chillon M, Danos O, (2000) Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer. J Virol 74: 505-512.
24. Prydal JI, Franc F, Dilly PN, Kerr Muir MG, Corbett MC, et al. (1998) Keratocyte density and size in conscious humans by digital image analysis of confocal images. Eye (Lond) 12 (Pt 3a): 337-342.
25. Joseph A, Hossain P, Jham S, Jones RE, Tighe P, et al. (2003) Expression of CD34 and L-selectin on human corneal keratocytes. Invest Ophthalmol Vis Sci 44: 4689-4692.
26. Espana EM, Kawakita T, Liu CY, Tseng SC, (2004) CD-34 expression by cultured human keratocytes is downregulated during myofibroblast differentiation induced by TGF-beta1. Invest Ophthalmol Vis Sci 45: 2985-2991.
27. Lai LJ, Xiao X, Wu JH, (2007) Inhibition of corneal neovascularization with endostatin delivered by adeno-associated viral (AAV) vector in a mouse corneal injury model. J Biomed Sci 14: 313-322.
28. Saika S, Ikeda K, Yamanaka O, Miyamoto T, Ohnishi Y, et al. (2005) Expression of Smad7 in mouse eyes accelerates healing of corneal tissue after exposure to alkali. Am J Pathol 166: 1405-1418.
29. Galiacy SD, Fournie P, Massoudi D, Ancele E, Quintyn JC, et al. (2011) Matrix metalloproteinase 14 overexpression reduces corneal scarring. Gene Ther 18: 462-468.
30. Beck M, (2007) New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy. Hum Genet 121: 1-22.
31. Kalatzis V, Serratrice N, Hippert C, Payet O, Arndt C, et al. (2007) The ocular anomalies in a cystinosis animal model mimic disease pathogenesis. Pediatr Res 62: 156-162.
32. Nesterova G, Gahl W, (2008) Nephropathic cystinosis: late complications of a multisystemic disease. Pediatr Nephrol 23: 863-878.
33. Fini ME, Stramer BM, (2005) How the cornea heals: cornea-specific repair mechanisms affecting surgical outcomes. Cornea 24: S2-S11.
34. Smith RH, (2008) Adeno-associated virus integration: virus versus vector. Gene Ther 15: 817-822.
35. Duan D, Sharma P, Yang J, Yue Y, Dudus L, et al. (1998) Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J Virol 72: 8568-8577.
36. Stieger K, Schroeder J, Provost N, Mendes-Madeira A, Belbellaa B, et al. (2009) Detection of intact rAAV particles up to 6 years after successful gene transfer in the retina of dogs and primates. Mol Ther 17: 516-523.
37. Johnson JS, Samulski RJ, (2009) Enhancement of adeno-associated virus infection by mobilizing capsids into and out of the nucleolus. J Virol 83: 2632-2644.
38. Tsai ML, Chen SL, Chou PI, Wen LY, Tsai RJ, et al. (2002) Inducible adeno-associated virus vector-delivered transgene expression in corneal endothelium. Invest Ophthalmol Vis Sci 43: 751-757.
39. Alexander IE, Russell DW, Miller AD, (1994) DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J Virol 68: 8282-8287.
40. Neufeld EF, (1991) Lysosomal storage diseases. Annu Rev Biochem 60: 257-280.
41. Kalatzis V, Cherqui S, Antignac C, Gasnier B, (2001) Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter. EMBO J 20: 5940-5949.
42. Du Y, Funderburgh ML, Mann MM, SundarRaj N, Funderburgh JL, (2005) Multipotent stem cells in human corneal stroma. Stem Cells 23: 1266-1275.
43. Du Y, Carlson EC, Funderburgh ML, Birk DE, Pearlman E, et al. (2009) Stem cell therapy restores transparency to defective murine corneas. Stem Cells 27: 1635-1642.
44. Weber M, Milligan L, Delalbre A, Antoine E, Brunel C, et al. (2001) Extensive tissue-specific variation of allelic methylation in the Igf2 gene during mouse fetal development: relation to expression and imprinting. Mech Dev 101: 133-141.
45. Hagege H, Nasser R, Weber M, Milligan L, Aptel N, et al. (2006) The 3′ portion of the mouse H19 Imprinting-Control Region is required for proper tissue-specific expression of the Igf2 gene. Cytogenet Genome Res 113: 230-237.
46. Lutfalla G, Uze G, (2006) Performing quantitative reverse-transcribed polymerase chain reaction experiments. Methods Enzymol 410: 386-400.
47. Weber M, Hagege H, Lutfalla G, Dandolo L, Brunel C, et al. (2003) A real-time polymerase chain reaction assay for quantification of allele ratios and correction of amplification bias. Anal Biochem 320: 252-258.